StockData
Actuate Therapeutics, Inc. logo

Actuate Therapeutics, Inc. (ACTU) stock

ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.25−0.02 (-6.12%)

Close on Nov 17, 2026Market cap $6.04MP/E –Yield –

Actuate Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Actuate Therapeutics's enterprise value was $2.83M on Nov 11, 2026, against $160.42M a year earlier. Over the last 2 years it ranged from $2.83M to $228.54M, with a median of $115.45M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.83M-97.7%
2025Dec 31, 2025$125.32M-11.7%
2024Dec 31, 2024$141.95M–

More Actuate Therapeutics figures

See a number that looks wrong?